ILSI-Biomed Israel

Avraham Pharmaceuticals: $9 M Funding for a Multy-functional Alzheimer drug

Avraham Pharmaceuticals Ltd. has raised $9 million from Yissum Research Development Company (the technology transfer arm of the Hebrew University of Jerusalem), Pontifax, Clal Biotechnology Industries (CBI), Professor Marta Weinstock-Rosin and others.   Yissum has announced that, together with the Technion Research and Development Foundation (TRDF), the technology transfer arm of the Technion Israel Institute of Technology, it will exclusively license to Avraham the commercial rights of La...